THE GLOBAL FRACTIONAL FLOW RESERVE MARKET SIZE WAS VALUED AT USD 734.91 MILLION IN 2021 AND IS EXPECTED TO REACH USD 1.4 BILLION BY 2027, GROWING AT A CAGR OF 12.34%.

Fractional Flow Reserve (FFR) Market Research Report Includes Market Size, Share, Trends, Growth drivers by following Segments: 

  • Technology: Invasive and Non-Invasive
  • Applications: Single-Vessel, and Multi-Vessel
  • End-Users:  Hospitals & Specialty Cardiac Centers, Office-Based Labs, Diagnostic Imaging Centers, and Others
  • Geography: North America, Europe, APAC, Latin America, and Middle East & Africa

Industry Analysis Report, Regional Outlook, Growth Trends, Competitive Landscape, Market Share & Forecast, 2020–2025

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

287 Pages

icon-table

118 Tables

icon-chart

141 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

8 Companies

icon-market

4 Market Segment

GLOBAL FRACTIONAL FLOW RESERVE MARKET REPORT SCOPE

Report Attribute Details
Market Size (2027) USD 734.91 Million
Market Size (2021) USD 1.4 Billion
CAGR (2021-2027) 12.34%
Base Year 2021
Forecast Year 2022-2027
Market Segments Technology(Invasive and Non-Invasive ), Application(Single-Vessel, and Multi-Vessel ), End-User( Hospitals & Specialty Cardiac Centers, Office-Based Labs, Diagnostic Imaging Centers, and Others ), and Geography
Geographic Analysis North America, Europe, APAC, Latin America, and Middle East & Africa

MARKET ANALYSIS

The global fractional flow reserve (FFR) market was valued at USD 734.9 million in 2021 and is expected to reach USD 1.4 billion by 2027, growing at a CAGR of 12% during the forecast period. The fractional flow reserve (FFR) is a gold standard for assessing coronary artery disease during invasive coronary angiography. The demand for FFR is increasing due to its increasing applications in improving patient outcomes, reducing stent insertion, and the cost of the treatment. The benefits of FFR are high; however, its usage is limited in the market. The FFR is commonly used to decide the need for revascularization. The usage of non-invasive fractional flow reserve systems is increasing due to innovative methods in healthcare systems. As a part of the standard procedure to diagnose coronary artery disease (CAD), multiple non-invasive tests are performed on the patients complaining of stable chest pain and low or intermediate probability of CAD. Chest pain remains the second most common reason for adult emergency visits in the United States.

The increasing target population globally drives the demand for FFR systems.

The increasing target population will be a major driving factor for the usage of FFR in the market. Cardiovascular diseases cause one-third of deaths worldwide. Ischemic heart disease (IHD) is one of the prevalent conditions. The IHD incidence is expected to increase due to an increase in obesity, metabolic syndrome, diabetic conditions, and the aged population. In the past two decades, there has been a significant increase in the aging population. According to the United Nations, one in every eleven people will be over 65 years old by 2050, up from one in every eleven in 2019. In addition, reduced physical activity, rapid urbanization, and globalization activities in LMICs have led to an increase in cardiovascular diseases, including IHD. In countries like the United States, the cost of IHD is approaching 1%-1.5% of the gross domestic product (GDP); in the case of LMICs, it accounts for 10% of total per capita healthcare expenditure. This increasing target population globally will drive the global fractional flow reserve market growth.

Technological Advancements Driving the Faster adoption of FFR.

The fractional flow reserve market is experiencing high technological advancements with non-invasive FFR methods. This trend is augmenting the demand and adoption of next-generation FFR products among healthcare providers and end-users. The vendors such as Boston Scientific, Philips, and ACIST Medical Systems have launched the next-generation products in the market. Artificial intelligence (AI) and machine learning also played an essential role in giving real patient experiences with FFR products. In comparison with conventional methods, AI technology has helped the end-users analyze a large volume of cases in a shorter duration and provide equal quality treatment to all the patients irrespective of the number of patients diagnosed at the same time. The end-users adopt image-based techniques such as FFR-CT and FFRangio more frequently due to the non-invasive assessment of coronary lesions.

SEGMENT ANALYSIS

Technology

The invasive fractional flow reserve systems are widely accepted as a standard technique for assessing the lesion-specific ischemic in patients with 50% to 90% of stenosis. The advancement in the invasive segment is limited. For instance, in 2020, Philips launched the first solid core pressure guidewire for the coronary interventional procedure.

The number of people admitted to the CATH labs is decreasing in developed countries due to the change in better diagnostics of coronary artery disease. The non-invasive method is revolutionizing the cardiac diagnostic segment. The FFR-CT has helped reduce the number of patients referred for unnecessary catheterization. There are many scenarios in which the patient is recommended for stents and other procedures without proper quality data, where invasive FFR is ineffective in diagnosing the patient's condition. The FFR-CT (non-invasive) has proven to be better than the FFR invasive, seen as a gatekeeper for CATH Labs in the market.

One of the primary reasons for the slower adoption of non-invasive FFR systems is that many clinicians still believe that angiography provides better results and that will be enough to decide the treatment pathway for the patients. It also depends on the local practitioners to determine the diagnostic steps; still, many prefer CT scans, nuclear tests, and Invasive angiography.

Application

The technological advancements in the market have made the clinicians diagnose the patient with multivessel diseases, which is a complex scenario for the invasive methods in the market. Non-invasive methods provide the 3D structure of the heart with the FFR value and indicate the possible stenosis locations. This is a major revolutionary product to treat patients with multivessel diseases. There is a constant increase in people admitted to hospitals suffering from multivessel diseases, especially in developing and developed countries.

End-User

Hospitals & Specialty Cardiac Centers: Hospitals are the first point of contact for any patients, especially during the emergency conditions like chest pain. This increases the number of people preferring the hospitals to undergo treatments, and Hospitals do invest in the latest technologies to attract better customers in the region. Most elective surgeries and complex cardiac surgeries are performed in specialty cardiac centers.

Office-Based Labs: It is one of the new evolutions in the laboratory spaces. The movement of people and doctors away from the hospitals to get better attention, and safer and quickest treatments are driving the demand for the new labs like office-based labs in the market.

Diagnostic Imaging Centers predominantly invest in advanced products to attract customers; they partner with a large number of clinics and hospitals providing the services indirectly. They are expected to grow at a faster CAGR during the forecast period.

Geography

Many developed countries like the US are shifting from the volume-based to value-based approach in the healthcare systems. This is making the developed countries prefer advanced products like FFR-CT. Some European countries prefer using value-based products to enhance their quality of treatments, which is not the case with developing countries like India, China, Brazil, Mexico, and Turkey. Still, the preference is majorly for volume-based treatments, which are economical and provide results to treat the patients.

North America: The United States dominated the global fractional flow reserve market globally. The faster adoption of value-based products in the healthcare system, better awareness among the clinicians, and increasing adoption of FFR-CT has made the US a major fractional flow reserve market shareholder.

Europe: Europe healthcare is a mixture of both values-based and volume-based healthcare providers. The adoption is faster among the value-based treatment providers. The adoption of advanced technologies is low in some of the developing economies in Europe. The increasing number of CATH Labs and office-based labs are mainly driving the usage of advanced products and boosting the non-invasive fractional flow reserve market.

APAC: The adoption of advanced products like FFR is limited in the region. There is a constant increase in the number of cardiovascular disease patients in the region, and the number of people undergoing diagnostics is increasing. The demand for invasive methods is still high in the APAC region compared to non-invasive techniques. Due to its increased potential in the market, it is expected to grow at its highest during the forecast period.

Latin America: Latin American countries are also seen as famous destinations for various medical treatments. The adoption of advanced technologies is high in urban hospitals to attract tourists. Due to lack of reimbursement, the usage by local patients is limited, and they prefer undergoing more economic tests in the market. In addition, the lack of skilled lab technicians also limits the people to use conventional methods in the market.

Middle East & Africa: The middle east& Africa region is growing at a lower CAGR than other countries. As per the recently available data, there are more than 1.1 billion people in that region, but only 20 countries have CATH labs. The potential for FFR-based products is high in the market due to the increased target population. The fractional flow reserve market demand will increase with more economical products.

VENDOR ANALYSIS

Abbott,   ACIST Medical Systems,   Boston Scientific, CathWorks, General Electric Company, Koninklijke Philips, Opsens, and Siemens Healthineers are key players in the global fractional flow reserve market.

Vendors like HeartFlow are applying advanced methodologies to launch better products. Their technology uses the competitional fluid dynamics model, proper segmentation of coronaries, helping to find the value through the place of interest, and produces an interactive image with the FFR values for the doctors to make accurate decisions. In addition, one of the major benefits of this FFR-CT is that it avoids the invasive angiogram and provides better results comparatively. In addition, they are also using AI technology for better enhancement of the results and accuracy in diagnostics.

CathWorks FFRangio received US FDA approval in 2018. In 2021, CathWorks System will receive National Reimbursement Approval in Japan.

Frequently Asked Questions

What is the estimated value of the global fractional flow market?

The global fractional flow reserve market was valued at USD 734.9 million in 2021 and is expected to reach USD 1.4 bn by 2027.

What is the growth rate of the global fractional flow market?

The global fractional flow reserve market is expected to grow at a CAGR of 12% during 2022-2027.

Which region has the highest growth rate in the Fractional Flow Reserve Market?

The Asia-Pacific region's fractional flow reserve market will witness the highest growth rate during 2022-2027.

Which region has the largest Fractional Flow Reserve Market share globally?

North America has the largest share. The United States is the dominating market globally.

Who are the key players in the FFR market?

Abbott, ACIST Medical Systems, Boston Scientific, CathWorks, General Electric Company, Koninklijke Philips, Opsens, and Siemens Healthineers are among the key players in the global fractional flow reserve market.

Download Free Sample

The global fractional flow reserve market was valued at USD 734.91 million in 2021 and is expected to reach USD 1.4 billion by 2027, growing at a CAGR of 12%. 

The following factors are likely to contribute to the fractional flow reserve market growth-  

  • New Technology Directions in FFR
  • Rising Patient Population in CVDs
  • Increasing Number of CATH Labs

Base Year: 2021  

Forecast Year: 2022-2027  

The study considers a detailed scenario of the present market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market. 

Key Vendors  

  • Abbott 
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • ACIST Medical Systems 
  • Boston Scientific
  • CathWorks
  • General Electric Company
  • Koninklijke Philips
  • Opsens
  • Siemens Healthineers

Segmentation by Technology  

  • Invasive
  • Non-Invasive

Segmentation by Applications 

  • Single-Vessel
  • Multi-Vessel

Segmentation by End-Users  

  • Hospitals & Specialty Cardiac Centers
  • Office-Based Labs
  • Diagnostic Imaging Centers
  • Others 

Segmentation by Geography  

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • South Africa
    • Saudi Arabia

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET BY TECHNOLOGY

4.3.2 MARKET BY APPLICATIONS

4.3.3 MARKET BY END-USER

4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

7.1.1 CAD DIAGNOSIS

7.2 FFR: AN OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

8.1 NEXT-GEN DEVICES AUGMENTING NON-INVASIVE FFR METHODS

8.2 FFR-OCT IMPROVING OUTCOMES IN DIABETIC PATIENTS

8.3 AI & ML REVOLUTIONIZING FFR-CT

9 MARKET GROWTH ENABLERS

9.1 NEW TECHNOLOGY DIRECTIONS IN FFR

9.2 RISING PATIENT POPULATION OF CVDS

9.3 INCREASING NUMBER OF CATH LABS

10 MARKET RESTRAINTS

10.1 HIGH COST OF FFR

10.2 TECHNICAL LIMITATIONS OF FFR

10.3 LOWER ADOPTION OF FFR & RISE OF SUBSTITUTES

11 MARKET LANDSCAPE

11.1 MARKET OVERVIEW

11.2 MARKET SIZE & FORECAST

11.2.1 GEOGRAPHY INSIGHTS

11.2.2 TECHNOLOGY INSIGHTS

11.2.3 APPLICATIONS INSIGHTS

11.2.4 END-USER INSIGHTS

11.3 FIVE FORCES ANALYSIS

11.3.1 THREAT OF NEW ENTRANTS

11.3.2 BARGAINING POWER OF SUPPLIERS

11.3.3 BARGAINING POWER OF BUYERS

11.3.4 THREAT OF SUBSTITUTES

11.3.5 COMPETITIVE RIVALRY

12 TECHNOLOGY

12.1 MARKET SNAPSHOT & GROWTH ENGINE

12.2 MARKET OVERVIEW

12.3 NON-INVASIVE

12.3.1 MARKET OVERVIEW

12.3.2 MARKET SIZE & FORECAST

12.3.3 NON-INVASIVE FFR BY GEOGRAPHY

12.4 INVASIVE

12.4.1 MARKET OVERVIEW

12.4.2 MARKET SIZE & FORECAST

12.4.3 INVASIVE FFR BY GEOGRAPHY

13 APPLICATIONS

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 SINGLE-VESSEL

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 SINGLE-VESSEL FFR BY GEOGRAPHY

13.4 MULTI-VESSEL

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MULTI-VESSEL FFR BY GEOGRAPHY

14 END-USER

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 HOSPITALS & SPECIALTY CARDIAC CENTERS

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 HOSPITALS & SPECIALTY CARDIAC CENTERS SEGMENTATION BY GEOGRAPHY

14.4 OFFICE-BASED LABS

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 OFFICE-BASED LABS FFR BY GEOGRAPHY

14.5 DIAGNOSTIC IMAGING CENTERS

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 DIAGNOSTIC IMAGING CENTERS SEGMENTATION BY GEOGRAPHY

14.6 OTHERS

14.6.1 MARKET OVERVIEW

14.6.2 MARKET SIZE & FORECAST

14.6.3 OTHERS SEGMENTATION BY GEOGRAPHY

15 GEOGRAPHY

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 GEOGRAPHIC OVERVIEW

16 NORTH AMERICA

16.1 MARKET OVERVIEW

16.2 MARKET SIZE & FORECAST

16.2.1 NORTH AMERICA BY TECHNOLOGY

16.2.2 NORTH AMERICA BY APPLICATIONS SEGMENTATION

16.2.3 NORTH AMERICA BY END-USERS

16.3 KEY COUNTRIES

16.3.1 US: MARKET SIZE & FORECAST

16.3.2 CANADA: MARKET SIZE & FORECAST

17 EUROPE

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.2.1 EUROPE BY TECHNOLOGY SEGMENTATION

17.2.2 EUROPE BY APPLICATIONS SEGMENTATION

17.2.3 EUROPE BY END-USER

17.3 KEY COUNTRIES

17.3.1 GERMANY: MARKET SIZE & FORECAST

17.3.2 FRANCE: MARKET SIZE & FORECAST

17.3.3 UK: MARKET SIZE & FORECAST

17.3.4 ITALY: MARKET SIZE & FORECAST

17.3.5 SPAIN: MARKET SIZE & FORECAST

18 APAC

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.2.1 APAC BY TECHNOLOGY SEGMENTATION

18.2.2 APAC BY APPLICATIONS SEGMENTATION

18.2.3 APAC BY END-USER SEGMENTATION

18.3 KEY COUNTRIES

18.3.1 JAPAN: MARKET SIZE & FORECAST

18.3.2 CHINA: MARKET SIZE & FORECAST

18.3.3 INDIA: MARKET SIZE & FORECAST

18.3.4 SOUTH KOREA: MARKET SIZE & FORECAST

18.3.5 AUSTRALIA: MARKET SIZE & FORECAST

19 LATIN AMERICA

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.2.1 LATIN AMERICA BY TECHNOLOGY SEGMENTATION

19.2.2 LATIN AMERICA BY APPLICATION SEGMENTATION

19.2.3 LATIN AMERICA BY END-USER SEGMENTATION

19.3 KEY COUNTRIES

19.3.1 BRAZIL: MARKET SIZE & FORECAST

19.3.2 MEXICO: MARKET SIZE & FORECAST

19.3.3 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.2.1 MIDDLE EAST & AFRICA BY TECHNOLOGY SEGMENTATION

20.2.2 MIDDLE EAST & AFRICA BY APPLICATIONS SEGMENTATION

20.2.3 MIDDLE EAST & AFRICA BY END-USER SEGMENTATION

20.3 KEY COUNTRIES

20.3.1 TURKEY: MARKET SIZE & FORECAST

20.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST

20.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

21.1 COMPETITION OVERVIEW

21.2 MARKET SHARE ANALYSIS

21.2.1 ABBOTT

21.2.2 ACIST MEDICAL SYSTEM

21.2.3 BOSTON SCIENTIFIC

21.2.4 CATHWORKS

21.2.5 GE HEALTHCARE

21.2.6 KONINKLIJKE PHILIPS

21.2.7 OPSENS

21.2.8 SIEMENS HEALTHINEERS

22 KEY COMPANY PROFILES

22.1 ABBOTT

22.1.1 BUSINESS OVERVIEW

22.1.2 PRODUCT OFFERINGS

22.1.3 KEY STRATEGIES

22.1.4 KEY STRENGTHS

22.1.5 KEY OPPORTUNITIES

22.2 ACIST MEDICAL SYSTEMS

22.2.1 BUSINESS OVERVIEW

22.2.2 PRODUCT OFFERINGS

22.2.3 KEY STRATEGIES

22.2.4 KEY STRENGTHS

22.2.5 KEY OPPORTUNITIES

22.3 BOSTON SCIENTIFIC

22.3.1 BUSINESS OVERVIEW

22.3.2 PRODUCT OFFERINGS

22.3.3 KEY STRATEGIES

22.3.4 KEY STRENGTHS

22.3.5 KEY OPPORTUNITIES

22.4 CATHWORKS

22.4.1 BUSINESS OVERVIEW

22.4.2 PRODUCT OFFERINGS

22.4.3 KEY STRATEGIES

22.4.4 KEY STRENGTHS

22.4.5 KEY OPPORTUNITIES

22.5 GE HEALTHCARE

22.5.1 BUSINESS OVERVIEW

22.5.2 PRODUCT OFFERINGS

22.5.3 KEY STRATEGIES

22.5.4 KEY STRENGTHS

22.5.5 KEY OPPORTUNITIES

22.6 KONINKLIJKE PHILIPS

22.6.1 BUSINESS OVERVIEW

22.6.2 PRODUCT OFFERINGS

22.6.3 KEY STRATEGIES

22.6.4 KEY STRENGTHS

22.6.5 KEY OPPORTUNITIES

22.7 OPSENS

22.7.1 BUSINESS OVERVIEW

22.7.2 PRODUCT OFFERINGS

22.7.3 KEY STRATEGIES

22.7.4 KEY STRENGTHS

22.7.5 KEY OPPORTUNITIES

22.8 SIEMENS HEALTHINEERS

22.8.1 BUSINESS OVERVIEW

22.8.2 PRODUCT OFFERINGS

22.8.3 KEY STRATEGIES

22.8.4 KEY STRENGTHS

22.8.5 KEY OPPORTUNITIES

23 REPORT SUMMARY

23.1 KEY TAKEAWAYS

23.2 STRATEGIC RECOMMENDATIONS

24 QUANTITATIVE SUMMARY

24.1 TECHNOLOGY

24.1.1 NORTH AMERICA BY TECHNOLOGY SEGMENTATION

24.1.2 EUROPE BY TECHNOLOGY SEGMENTATION

24.1.3 APAC BY TECHNOLOGY SEGMENTATION

24.1.4 LATIN AMERICA BY TECHNOLOGY SEGMENTATION

24.1.5 MIDDLE EAST & AFRICA BY TECHNOLOGY SEGMENTATION

24.2 APPLICATION

24.2.1 NORTH AMERICA BY APPLICATION SEGMENTATION

24.2.2 EUROPE BY APPLICATION SEGMENTATION

24.2.3 APAC BY APPLICATION SEGMENTATION

24.2.4 LATIN AMERICA BY APPLICATIONS SEGMENTATION

24.2.5 MIDDLE EAST & AFRICA BY APPLICATION SEGMENTATION

24.3 END-USER

24.3.1 NORTH AMERICA BY END-USER SEGMENTATION

24.3.2 EUROPE BY END-USER SEGMENTATION

24.3.3 APAC BY END-USER SEGMENTATION

24.3.4 LATIN AMERICA BY END-USER SEGMENTATION

24.3.5 MIDDLE EAST & AFRICA BY END-USER SEGMENTATION

24.4 GEOGRAPHY

24.4.1 INVASIVE SEGMENTATION BY GEOGRAPHY

24.4.2 NON-INVASIVE SEGMENTATION BY GEOGRAPHY

24.4.3 SINGLE-VESSEL SEGMENTATION BY GEOGRAPHY

24.4.4 MULTI-VESSEL SEGMENTATION BY GEOGRAPHY

24.4.5 HOSPITALS & SPECIALTY CARDIAC CENTERS SEGMENTATION BY GEOGRAPHY

24.4.6 OFFICE-BASED LABS SEGMENTATION BY GEOGRAPHY

24.4.7 DIAGNOSTIC IMAGING CENTERS SEGMENTATION BY GEOGRAPHY

24.4.8 OTHERS SEGMENTATION BY GEOGRAPHY

25 APPENDIX

25.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL FRACTIONAL FLOW RESERVE (FFR) MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 IMPACT OF NEXT-GEN DEVICES AUGMENTING NON-INVASIVE FFR METHODS

EXHIBIT 4 ACIST RXI MINI SYSTEM FEATURES

EXHIBIT 5 IMPACT OF FFR-OCT IMPROVING OUTCOMES IN DIABETIC PATIENTS

EXHIBIT 6 GLOBAL INCREASE OF TARGET POPULATION

EXHIBIT 7 IMPACT OF AI & ML REVOLUTIONIZING FFR-CT

EXHIBIT 8 IMPACT OF NEW TECHNOLOGY DIRECTIONS IN FFR

EXHIBIT 9 IMPACT OF RISING PATIENT POPULATION OF  CVDS

EXHIBIT 10 INDICATIONS FOR FFR MANAGEMENT

EXHIBIT 11 IMPACT OF INCREASING NUMBER OF CATH LABS

EXHIBIT 12 HOSPITALS WITH CATHETERIZATION LABORATORIES AND ON-SITE CARDIAC SURGERY PER MILLION PEOPLE

EXHIBIT 13 IMPACT OF HIGH COST OF FFR

EXHIBIT 14 IMPACT OF TECHNICAL LIMITATIONS OF FFR

EXHIBIT 15 IMPACT OF LOWER ADOPTION OF FFR & RISE OF SUBSTITUTES

EXHIBIT 16 GLOBAL FFR MARKET 2021–2027 ($ MILLION)

EXHIBIT 17 GLOBAL FFR MARKET BY GEOGRAPHY (% SHARE)

EXHIBIT 18 GLOBAL FFR MARKET BY TECHNOLOGY (% SHARE)

EXHIBIT 19 GLOBAL FFR MARKET BY APPLICATIONS (% SHARE)

EXHIBIT 20 GLOBAL FFR MARKET BY END-USERS (% SHARE)

EXHIBIT 21 FIVE FORCES ANALYSIS 2021

EXHIBIT 22 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 23 GLOBAL FFR BY TECHNOLOGY

EXHIBIT 24 GLOBAL FFR MARKET BY TECHNOLOGY: OVERVIEW

EXHIBIT 25 GLOBAL FFR MARKET BY TECHNOLOGY: INCREMENTAL GROWTH

EXHIBIT 26 GLOBAL FFR MARKET BY TECHNOLOGY: ABSOLUTE GROWTH

EXHIBIT 27 GROWTH ANALYSIS: GLOBAL FFR MARKET BY TECHNOLOGY

EXHIBIT 28 GLOBAL FFR MARKET BY NON-INVASIVE: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 29 GLOBAL NON-INVASIVE FFR MARKET 2021–2027 ($ MILLION)

EXHIBIT 30 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 31 GLOBAL INVASIVE FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 32 GLOBAL INVASIVE FFR MARKET 2021–2027 ($ MILLION)

EXHIBIT 33 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 34 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027

EXHIBIT 35 GLOBAL FFR MARKET BY APPLICATIONS

EXHIBIT 36 GLOBAL FFR MARKET BY APPLICATION: OVERVIEW

EXHIBIT 37 GLOBAL FFR MARKET BY APPLICATIONS: INCREMENTAL GROWTH

EXHIBIT 38 GLOBAL FFR MARKET BY APPLICATIONS: ABSOLUTE GROWTH

EXHIBIT 39 GLOBAL SINGLE-VESSEL FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 40 GLOBAL SINGLE-VESSEL FFR MARKET 2021–2027 ($ MILLION)

EXHIBIT 41 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 42 GLOBAL MULTI-VESSEL FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 43 GLOBAL MULTI-VESSEL FFR MARKET 2021–2027 ($ MILLION)

EXHIBIT 44 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 45 INCREMENTAL GROWTH BY END-USERS 2021 & 2027

EXHIBIT 46 GLOBAL FFR MARKET BY END-USER

EXHIBIT 47 GLOBAL FFR MARKET BY END-USER: OVERVIEW

EXHIBIT 48 GLOBAL FFR MARKET BY END-USERS: INCREMENTAL GROWTH

EXHIBIT 49 GLOBAL FFR MARKET BY END-USERS: ABSOLUTE GROWTH

EXHIBIT 50 GROWTH ANALYSIS: FFR MARKET BY END-USER

EXHIBIT 51 GLOBAL FFR MARKET BY HOSPITALS & SPECIALTY CARDIAC CENTERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 52 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET 2021–2027 ($ MILLION)

EXHIBIT 53 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 54 GLOBAL FFR MARKET BY OFFICE-BASED LABS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 55 GLOBAL OFFICE-BASED LABS IN FFR MARKET 2021–2027 ($ MILLION)

EXHIBIT 56 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 57 GLOBAL FFR MARKET BY DIAGNOSTIC IMAGING CENTERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 58 GLOBAL FFR MARKET BY DIAGNOSTIC IMAGING CENTERS 2021–2027 ($ MILLION)

EXHIBIT 59 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 60 GLOBAL FFR MARKET BY OTHER END-USERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 61 GLOBAL FFR MARKET BY OTHER END-USERS 2021–2027 ($ MILLION)

EXHIBIT 62 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 63 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 64 GLOBAL FFR MARKET BY GEOGRAPHY

EXHIBIT 65 GLOBAL FFR MARKET BY GEOGRAPHY: INCREMENTAL GROWTH

EXHIBIT 66 GLOBAL FFR MARKET BY GEOGRAPHY: ABSOLUTE GROWTH

EXHIBIT 67 FFR MARKET IN NORTH AMERICA: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 68 NORTH AMERICA FFR MARKET: KEY COUNTRIES

EXHIBIT 69 FFR MARKET IN NORTH AMERICA 2021–2027 ($ MILLION)

EXHIBIT 70 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 71 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027

EXHIBIT 72 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 73 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 74 FRACTIONAL FLOW RESERVE MARKET IN THE US 2021–2027 ($ MILLION)

EXHIBIT 75 FFR MARKET IN CANADA 2021–2027 ($ MILLION)

EXHIBIT 76 CANADIAN RISKY LIFESTYLE PRACTICES

EXHIBIT 77 FFR MARKET IN EUROPE: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 78 HOSPITALS WITH 24/7 CATH LABS PER MILLION IN EUROPE

EXHIBIT 79 EUROPE FFR MARKET: KEY COUNTRIES

EXHIBIT 80 FFR MARKET IN EUROPE 2021–2027 ($ MILLION)

EXHIBIT 81 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 82 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027

EXHIBIT 83 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 84 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 85 FFR MARKET IN GERMANY 2021–2027 ($ MILLION)

EXHIBIT 86 FFR MARKET IN FRANCE 2021–2027 ($ MILLION)

EXHIBIT 87 FFR MARKET IN UK 2021–2027 ($ MILLION)

EXHIBIT 88 FFR MARKET IN ITALY 2021–2027 ($ MILLION)

EXHIBIT 89 FFR MARKET IN SPAIN 2021–2027 ($ MILLION)

EXHIBIT 90 FFR MARKET IN APAC: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 91 FFR MARKET IN APAC: KEY COUNTRIES

EXHIBIT 92 FFR MARKET IN APAC 2021–2027 ($ MILLION)

EXHIBIT 93 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 94 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027

EXHIBIT 95 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 96 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 97 FFR MARKET IN JAPAN 2021–2027 ($ MILLION)

EXHIBIT 98 FFR MARKET IN CHINA 2021–2027 ($ MILLION)

EXHIBIT 99 FFR MARKET IN INDIA 2021–2027 ($ MILLION)

EXHIBIT 100 FFR MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)

EXHIBIT 101 FFR MARKET IN AUSTRALIA 2021–2027 ($ MILLION)

EXHIBIT 102 FFR MARKET IN LATIN AMERICA: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 103 LATIN AMERICA FFR MARKET: KEY COUNTRIES

EXHIBIT 104 FFR MARKET IN LATIN AMERICA 2021–2027 ($ MILLION)

EXHIBIT 105 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 106 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027

EXHIBIT 107 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 108 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 109 FRACTIONAL FLOW RESERVE MARKET IN BRAZIL 2021–2027 ($ MILLION)

EXHIBIT 110 FFR MARKET IN MEXICO 2021–2027 ($ MILLION)

EXHIBIT 111 FFR MARKET IN ARGENTINA 2021–2027 ($ MILLION)

EXHIBIT 112 MIDDLE EAST & AFRICA FFR MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 113 MIDDLE EAST & AFRICA FFR MARKET: KEY COUNTRIES

EXHIBIT 114 FFR MARKET IN MIDDLE EAST & AFRICA 2021–2027 ($ MILLION)

EXHIBIT 115 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027

EXHIBIT 116 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027

EXHIBIT 117 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 118 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 119 FFR MARKET IN TURKEY 2021–2027 ($ MILLION)

EXHIBIT 120 FFR MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)

EXHIBIT 121 FFR MARKET IN SOUTH AFRICA 2021–2027 ($ MILLION)

EXHIBIT 122 PURE& DIVERSIFIED COMPANIES IN GLOBAL FFR MARKET

EXHIBIT 123 GLOBAL FFR MARKET: MARKET DOMINANCE ANALYSIS

EXHIBIT 124 VENDORS IN GLOBAL FFR MARKET: CAPABILITIES & EXPERTISE ASSESSMENT

EXHIBIT 125 ABBOTT: TOTAL REVENUE 2019-2021 ($ MILLIONS)

EXHIBIT 126 ABBOTT: R&D EXPENDITURE 2019-2021 ($ MILLIONS)

EXHIBIT 127 ABBOTT: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)

EXHIBIT 128 ABBOTT: REVENUE BY GEOGRAPHY 2021 ($ MILLIONS)

EXHIBIT 129 BOSTON SCIENTIFIC: TOTAL REVENUE 2019-2021 ($ MILLIONS)

EXHIBIT 130 BOSTON SCIENTIFIC: R&D EXPENDITURE 2019-2021 ($ MILLIONS)

EXHIBIT 131 BOSTON SCIENTIFIC: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)

EXHIBIT 132 BOSTON SCIENTIFIC: REVENUE BY GEOGRAPHY 2021 ($ MILLIONS)

EXHIBIT 133 GE HEALTHCARE: TOTAL REVENUE 2019-2021 ($ MILLIONS)

EXHIBIT 134 GE HEALTHCARE: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)

EXHIBIT 135 GE HEALTHCARE: REVENUE BY GEOGRAPHY 2021 ($ MILLIONS)

EXHIBIT 136 KONINKLIJKE PHILIPS: TOTAL REVENUE 2019-2021 ($ MILLIONS)

EXHIBIT 137 KONINKLIJKE PHILIPS: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLIONS)

EXHIBIT 138 OPSENS: TOTAL REVENUE 2019-2021 ($ MILLIONS)

EXHIBIT 139 OPSENS: R&D EXPENDITURE 2019-2021 ($ MILLIONS)

EXHIBIT 140 SIEMENS HEALTHINEERS: TOTAL REVENUE 2019-2021 ($ MILLION)

EXHIBIT 141 SIEMENS HEALTHINEERS: R&D SPENDING 2019–2021 ($ MILLION)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 TREATMENT FOR CORONARY ARTERY DISEASE

TABLE 4 EXAMPLES OF NEXT-GENERATION FFR PRESSURE WIRE CHARACTERISTICS

TABLE 5 COMPARISON OF IMAGE-DERIVED FFR SYSTEM

TABLE 6 APPROXIMATE COSTING FOR STAGES IN FFR CT

TABLE 7 FFR PRESSURE GUIDEWIRE FAILURE AND ASSOCIATED ADVERSE EVENTS COMPARISON AMONG DIFFERENT GUIDEWIRES

TABLE 8 GLOBAL NON-INVASIVE FFR MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)

TABLE 9 GLOBAL NON-INVASIVE FFR MARKET BY GEOGRAPHY 2021−2027 (%)

TABLE 10 COMPARISON OF INVASIVE FFR MONITORING METHODS WITH SPECIFICATIONS

TABLE 11 GLOBAL INVASIVE FFR MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)

TABLE 12 GLOBAL INVASIVE FFR MARKET BY GEOGRAPHY 2021−2027 (%)

TABLE 13 GLOBAL SINGLE-VESSEL FFR MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)

TABLE 14 SINGLE-VESSEL IN FFR MARKET BY GEOGRAPHY 2021−2027 (%)

TABLE 15 GLOBAL MULTI-VESSEL FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 16 GLOBAL MULTI-VESSEL FFR MARKET BY GEOGRAPHY 2021-2027 (%)

TABLE 17 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 18 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)

TABLE 19 OFFICE-BASED LABS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 20 OFFICE-BASED LABS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)

TABLE 21 DIAGNOSTIC IMAGING CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 22 DIAGNOSTIC IMAGING CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)

TABLE 23 OTHER END-USERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 24 OTHER END-USERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)

TABLE 25 FFR MARKET BY TECHNOLOGY IN NORTH AMERICA 2021-2027 ($ MILLION)

TABLE 26 FFR MARKET BY TECHNOLOGY IN NORTH AMERICA 2021-2027 (%)

TABLE 27 FFR MARKET BY APPLICATIONS IN NORTH AMERICA 2021-2027 ($ MILLION)

TABLE 28 FFR MARKET BY APPLICATIONS IN NORTH AMERICA 2021-2027 (%)

TABLE 29 FFR MARKET BY END-USER IN NORTH AMERICA 2021-2027 ($ MILLION)

TABLE 30 FFR MARKET BY END-USER IN NORTH AMERICA 2021-2027 (%)

TABLE 31 FFR MARKET BY TECHNOLOGY IN EUROPE 2021-2027 ($ MILLION)

TABLE 32 FFR MARKET BY TECHNOLOGY IN EUROPE 2021-2027 (%)

TABLE 33 FFR MARKET BY APPLICATIONS IN EUROPE 2021-2027 ($ MILLION)

TABLE 34 FFR MARKET BY APPLICATIONS IN EUROPE 2021-2027 (%)

TABLE 35 FFR MARKET BY END-USER IN EUROPE 2021-2027 ($ MILLION)

TABLE 36 FFR MARKET BY END-USER IN EUROPE 2021-2027 (%)

TABLE 37 PREVALENCE OF CVD AND ITS SUBTYPE IN PATIENTS WITH TYPE 2 DIABETES IN ITALY (%)

TABLE 38 FFR MARKET BY TECHNOLOGY IN APAC 2021-2027 ($ MILLION)

TABLE 39 FFR MARKET BY TECHNOLOGY IN APAC 2021-2027 (%)

TABLE 40 FFR MARKET BY APPLICATIONS IN APAC 2021-2027 ($ MILLION)

TABLE 41 FFR MARKET BY APPLICATIONS IN APAC 2021-2027 (%)

TABLE 42 FFR MARKET BY END-USER IN APAC 2021-2027 ($ MILLION)

TABLE 43 FFR MARKET BY END-USER IN APAC 2021-2027 (%)

TABLE 44 KOREAN ADULTS WITH CARDIOVASCULAR RISK FACTORS

TABLE 45 FFR MARKET BY TECHNOLOGY IN LATIN AMERICA 2021-2027 ($ MILLION)

TABLE 46 FFR MARKET BY TECHNOLOGY IN LATIN AMERICA 2021-2027 (%)

TABLE 47 FFR MARKET BY APPLICATIONS IN LATIN AMERICA 2021-2027 ($ MILLION)

TABLE 48 FFR MARKET BY APPLICATIONS IN LATIN AMERICA 2021-2027 (%)

TABLE 49 FFR MARKET BY END-USER IN LATIN AMERICA 2021-2027 ($ MILLION)

TABLE 50 FFR MARKET BY END-USER IN LATIN AMERICA 2021-2027 (%)

TABLE 51 FFR MARKET BY TECHNOLOGY IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)

TABLE 52 FFR MARKET BY TECHNOLOGY IN MIDDLE EAST & AFRICA 2021-2027 (%)

TABLE 53 FFR MARKET BY APPLICATIONS IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)

TABLE 54 FFR MARKET BY APPLICATIONS IN MIDDLE EAST & AFRICA 2021-2027 (%)

TABLE 55 FFR MARKET BY END-USER IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)

TABLE 56 FFR MARKET BY END-USER IN MIDDLE EAST & AFRICA 2021-2027 (%)

TABLE 57 ABBOTT: MAJOR PRODUCT OFFERINGS

TABLE 58 ACIST MEDICAL SYSTEM: MAJOR PRODUCT OFFERINGS

TABLE 59 BOSTON SCIENTIFIC: MAJOR PRODUCT OFFERINGS

TABLE 60 CATHWORKS: MAJOR PRODUCT OFFERINGS

TABLE 61 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 62 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS

TABLE 63 OPSENS: MAJOR PRODUCT OFFERINGS

TABLE 64 SIEMENS HEALTHINEERS: MAJOR PRODUCT OFFERINGS

TABLE 65 GLOBAL FFR MARKET BY TECHNOLOGY 2021-2027 ($ MILLION)

TABLE 66 GLOBAL FFR MARKET BY TECHNOLOGY 2021-2027 (%)

TABLE 67 FFR MARKET BY TECHNOLOGY IN NORTH AMERICA 2021-2027 ($ MILLION)

TABLE 68 FFR MARKET BY TECHNOLOGY IN NORTH AMERICA 2021-2027 (%)

TABLE 69 FFR MARKET BY TECHNOLOGY IN EUROPE 2021-2027 ($ MILLION)

TABLE 70 FFR MARKET BY TECHNOLOGY IN EUROPE 2021-2027 (%)

TABLE 71 FFR MARKET BY TECHNOLOGY IN APAC 2021-2027 ($ MILLION)

TABLE 72 FFR MARKET BY TECHNOLOGY IN APAC 2021-2027 (%)

TABLE 73 FFR MARKET BY TECHNOLOGY IN LATIN AMERICA 2021-2027 ($ MILLION)

TABLE 74 FFR MARKET BY TECHNOLOGY IN LATIN AMERICA 2021-2027 (%)

TABLE 75 FFR MARKET BY TECHNOLOGY IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)

TABLE 76 FFR MARKET BY TECHNOLOGY IN MIDDLE EAST & AFRICA 2021-2027 (%)

TABLE 77 GLOBAL FFR MARKET BY APPLICATION 2021-2027 ($ MILLION)

TABLE 78 GLOBAL FFR MARKET BY APPLICATION 2021-2027 (%)

TABLE 79 FFR MARKET BY APPLICATION IN NORTH AMERICA 2021-2027 ($ MILLION)

TABLE 80 FFR MARKET BY APPLICATION IN NORTH AMERICA 2021-2027 (%)

TABLE 81 FFR MARKET BY APPLICATION IN EUROPE 2021-2027 ($ MILLION)

TABLE 82 FFR MARKET BY APPLICATION IN EUROPE 2021-2027 (%)

TABLE 83 FFR MARKET BY APPLICATION IN APAC 2021-2027 ($ MILLION)

TABLE 84 FFR MARKET BY APPLICATION IN APAC 2021-2027 (%)

TABLE 85 FFR MARKET BY APPLICATION IN LATIN AMERICA 2021-2027 ($ MILLION)

TABLE 86 FFR MARKET BY APPLICATION IN LATIN AMERICA 2021-2027 (%)

TABLE 87 FFR MARKET BY APPLICATION IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)

TABLE 88 FFR MARKET BY APPLICATION IN MIDDLE EAST & AFRICA 2021-2027 (%)

TABLE 89 GLOBAL FFR MARKET BY END-USER 2021-2027 ($ MILLION)

TABLE 90 GLOBAL FFR MARKET BY END-USER 2021-2027 (%)

TABLE 91 FFR MARKET BY END-USER IN NORTH AMERICA 2021-2027 ($ MILLION)

TABLE 92 FFR MARKET BY END-USER IN NORTH AMERICA 2021-2027 (%)

TABLE 93 FFR MARKET BY END-USER IN EUROPE 2021-2027 ($ MILLION)

TABLE 94 FFR MARKET BY END-USER IN EUROPE 2021-2027 (%)

TABLE 95 FFR MARKET BY END-USER IN APAC 2021-2027 ($ MILLION)

TABLE 96 FFR MARKET BY END-USER IN APAC 2021-2027 (%)

TABLE 97 FFR MARKET BY END-USER IN LATIN AMERICA 2021-2027 ($ MILLION)

TABLE 98 FFR MARKET BY END-USER IN LATIN AMERICA 2021-2027 (%)

TABLE 99 FFR MARKET BY END-USER IN MIDDLE EAST & AFRICA 2021-2027 ($ MILLION)

TABLE 100 FFR MARKET BY END-USER IN MIDDLE EAST & AFRICA 2021-2027 (%)

TABLE 101 GLOBAL FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 102 GLOBAL FFR MARKET BY GEOGRAPHY 2021-2027 (%)

TABLE 103 INVASIVE IN FFR MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)

TABLE 104 INVASIVE IN FFR MARKET BY GEOGRAPHY 2021−2027 (%)

TABLE 105 NON-INVASIVE IN FFR MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)

TABLE 106 NON-INVASIVE IN FFR MARKET BY GEOGRAPHY 2021−2027 (%)

TABLE 107 GLOBAL SINGLE-VESSEL IN FFR MARKET BY GEOGRAPHY 2021−2027 ($ MILLION)

TABLE 108 GLOBAL SINGLE-VESSEL IN FFR MARKET BY GEOGRAPHY 2021−2027 (%)

TABLE 109 GLOBAL MULTI-VESSEL IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 110 GLOBAL MULTI-VESSEL IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)

TABLE 111 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 112 GLOBAL HOSPITALS & SPECIALTY CARDIAC CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)

TABLE 113 GLOBAL OFFICE-BASED LABS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 114 GLOBAL OFFICE-BASED LABS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)

TABLE 115 DIAGNOSTIC IMAGING CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 116 DIAGNOSTIC IMAGING CENTERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)

TABLE 117 OTHER END-USERS IN FFR MARKET BY GEOGRAPHY 2021-2027 ($ MILLION)

TABLE 118 OTHER END-USERS IN FFR MARKET BY GEOGRAPHY 2021-2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3500.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$3995.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$4995.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date